DGAP-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Preliminary Result/Plan figures
Limes Schlosskliniken AG: Preliminary Group figures for 2021 (unaudited) – Outlook for 2022
18.01.2022 / 11:27 CET/CEST
Disclosure of inside information according to Article 17 of Regulation (EU) No. 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer / publisher is responsible for the content of the notification.
DGAP-Adhoc: Limes Schlosskliniken AG:
Preliminary Group figures for 2021 (unaudited) – Outlook for 2022
– Revenues EUR 16.9 million; (previous year EUR 11.2 million) +51%
– Gross profit for the period (EBITDA) +5,394 kEUR; (previous year +838 kEUR)
– Operating result (EBIT) + 3,505 kEUR; (previous year -427 kEUR)
– Earnings before taxes (EBT) +3,284 kEUR; (previous year -693 kEUR)
Cologne, January 18, 2022: The LIMES Schlosskliniken Group was able to record positive business development in the 2021 financial year. Without the consolidation of the acquired Swiss clinic Paracelsus Recovery Group, LIMES Schlosskliniken were able to increase sales to EUR 16.9 million (+ 51%) and generate positive operating earnings before interest and depreciation (EBITDA) of EUR 5,394 thousand. The operating profit before interest (EBIT) amounts to EUR 3,505 thousand. The consolidated profit before taxes will be EUR 3,284 thousand. The business figures include EUR 641,000 in depreciation for the start-up of business operations. The use of loss carryforwards only results in a minimum taxation.
For 2022, including the consolidation of the Paracelsus Recovery Group, we expect sales of EUR 27.0 million (+ 60%). The operating result (EBITDA) should amount to approx. EUR 7.6 million. We expect an operating result (EBIT) of EUR 5.4 million. The start-up losses for the new “LIMES Schlossklinik Bergisches Land” clinic in the amount of EUR 1.3 million have already been taken into account in the planning estimates for the 2022 financial year. The commissioning of the new clinic is planned for September 1st, 2022. After a certain start-up phase, we expect additional sales of EUR 18.0 million with a capacity utilization of 80%.
Short profile: The LIMES Schlosskliniken Group operates high-quality private clinics for stress-related illnesses, mental and emotional disorders, such as B. Depression, affective disorders and acute burnout conditions. The offer is aimed at private patients, those entitled to benefits and self-payers. The LIMES Schlosskliniken Group stand for the special approach of relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. More information is below www.limes-schlosskliniken.de available.
Your contact for questions:
LIMES Schlosskliniken AG, Petra Kaes, Investor Relations
Kaiser-Wilhelm-Ring 26, 50672 Cologne
Tel.: 02203 / 29014-202, [email protected], www.limes-schlosskliniken.de
Language: German
Company: LIMES Schlosskliniken AG, Kaiser-Wilhelm-Ring 26, 50672 Cologne, Germany
Telephone: 49 2203 29014-202
Fax: 49 2203 29014-201
Email: [email protected]
Internet: www.limes-schlosskliniken.de
ISIN: DE000A0JDBC7
WKN: AOJDBC
Stock exchanges: Düsseldorf Freiverkehr, primary market, XETRA
end of message
01/18/2022 CET/CEST The DGAP distribution services include legal reporting requirements, corporate news/financial news and press releases.
Media archive at http://www.dgap.de